These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23030716)

  • 1. Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss.
    Pastore AL; Mariani S; Barrese F; Palleschi G; Valentini AM; Pacini L; Petrozza V; Carbone A; Cappa M
    J Endourol; 2013 Jan; 27(1):68-70. PubMed ID: 23030716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral Resection of Prostate and Bleeding: A Prospective, Randomized, Double-Blind Placebo-Controlled Trial to See the Efficacy of Short-Term Use of Finasteride and Dutasteride on Operative Blood Loss and Prostatic Microvessel Density.
    Bansal A; Arora A
    J Endourol; 2017 Sep; 31(9):910-917. PubMed ID: 28650680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates.
    Busetto GM; Giovannone R; Antonini G; Rossi A; Del Giudice F; Tricarico S; Ragonesi G; Gentile V; De Berardinis E
    BJU Int; 2015 Jul; 116(1):117-23. PubMed ID: 25291499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood loss and postoperative complications associated with transurethral resection of the prostate after pretreatment with dutasteride.
    Hahn RG; Fagerström T; Tammela TL; Van Vierssen Trip O; Beisland HO; Duggan A; Morrill B
    BJU Int; 2007 Mar; 99(3):587-94. PubMed ID: 17407516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term dutasteride and Serenoa repens on perioperative bleeding and microvessel density in patients undergoing transurethral resection of the prostate.
    Tuncel A; Ener K; Han O; Nalcacioglu V; Aydin O; Seckin S; Atan A
    Scand J Urol Nephrol; 2009; 43(5):377-82. PubMed ID: 19921983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.
    Zhu YP; Dai B; Zhang HL; Shi GH; Ye DW
    BMC Urol; 2015 Jun; 15():47. PubMed ID: 26032962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of dutasteride on reduction of intraoperative bleeding related to transurethral resection of the prostate].
    Boccon-Gibod L; Valton M; Ibrahim H; Boccon-Gibod L; Comenducci A
    Prog Urol; 2005 Dec; 15(6):1085-9. PubMed ID: 16429657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review and Meta-Analysis of the Effects on Dutasteride Treatment for Reducing Surgical Blood Loss during Transurethral Resection of the Prostate.
    Ren J; Lai S; Jiang Z; Xu X; Diao T; Thiruchelvam N; Zhang G
    Urol Int; 2017; 98(4):456-465. PubMed ID: 28006778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of one month treatment with dutasteride on transurethral resection of the prostate].
    Arratia-Maqueo JA; Garza-Cortés R; Gómez-Guerra LS; Cortés-González JR
    Actas Urol Esp; 2010 Nov; 34(10):866-9. PubMed ID: 21159282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Preoperative Finasteride on the Volume or Length Density of Prostate Vessels, Intraoperative, Postoperative Blood Loss during and after Monopolar Transurethral Resection of Prostate: A Dose Escalation Randomized Clinical Trial Using Stereolog Methods.
    Aminsharifi A; Salehi A; Noorafshan A; Aminsharifi A; Alnajar K
    Urol J; 2016 Mar; 13(1):2562-8. PubMed ID: 26945662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of two weeks of treatment with dutasteride on bleeding after transurethral resection of the prostate.
    Kim KS; Jeong WS; Park SY; Kim YT; Moon HS
    World J Mens Health; 2015 Apr; 33(1):14-9. PubMed ID: 25927058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term dutasteride therapy on prostate vascularity in patients with benign prostatic hyperplasia: a pilot study.
    Kravchick S; Cytron S; Mamonov A; Peled R; Linov L
    Urology; 2009 Jun; 73(6):1274-8. PubMed ID: 19375786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 5α-reductase inhibitors for patients with large benign prostatic hyperplasia (>80 mL) after transurethral resection of the prostate.
    Qian X; Yu G; Qian Y; Xu D; Liu H; Kong X; Zhu Y; Wang Z; Zheng J; Qi J
    Aging Male; 2015; 18(4):238-43. PubMed ID: 26225794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dutasteride, who is it more effective for? Second to fourth digit ratio and the relationship with prostate volume reduction by dutasteride treatment.
    Kim TB; Oh JK; Kim KH; Jung H; Yoon SJ; Lee MS; Kim SW
    BJU Int; 2012 Dec; 110(11 Pt C):E857-63. PubMed ID: 22755506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.
    Zong HT; Peng XX; Yang CC; Zhang Y
    Asian J Androl; 2011 Nov; 13(6):812-8. PubMed ID: 21892196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications.
    Berger AP; Wirtenberger W; Bektic J; Steiner H; Spranger R; Bartsch G; Horninger W
    J Urol; 2004 Jan; 171(1):289-91. PubMed ID: 14665896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-surgical finasteride therapy in patients treated endoscopically for benign prostatic hyperplasia.
    Crea G; Sanfilippo G; Anastasi G; Magno C; Vizzini C; Inferrera A
    Urol Int; 2005; 74(1):51-3. PubMed ID: 15711109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dutasteride on the efficacy of photoselective vaporization of the prostate: results of a randomized, placebo-controlled, double-blind study (DOP trial).
    Bepple JL; Barone BB; Eure G
    Urology; 2009 Nov; 74(5):1101-4. PubMed ID: 19800668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.